Thomas Trimarchi

Thomas Trimarchi, Ph.D. is the Chief Product Officer and has served in roles of increasing responsibility since joining BridgeBio in April 2018. Dr. Trimarchi has also served as a member of the board of directors of their affiliate, ML Bio Solutions, Inc., since November 2021. Prior to joining the Company, Dr. Trimarchi worked in corporate strategy at Regeneron Pharmaceuticals, Inc. and as an equity analyst in the Global Investment Research division at Goldman Sachs.

Dr. Trimarchi received his Ph.D. in Molecular Oncology and Immunology, Cell and Molecular Biology from New York University and a B.S. in Biology from the University of Vermont.